Trial Profile
Compare Efficacy and Safety Between Biologics + Methotrexate (MTX) vs Biologics + Tacrolimus (TAC) (Switched From Biologics + Methotrexate (MTX)) in the Patients With Rheumatoid Arthritis (RA): Randomized, Interventional, Open, Active Controlled, Parallel Group, Multicenter-designed, Phase 4 Clinical Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Abatacept; Adalimumab; Methotrexate; Tocilizumab
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Astellas Pharma Korea
- 15 Jul 2020 Status changed from active, no longer recruiting to completed.
- 20 Apr 2020 Planned End Date changed from 1 Feb 2021 to 1 Jun 2020.
- 20 Apr 2020 Planned primary completion date changed from 1 Feb 2021 to 1 Jun 2020.